Renewed hope for treatment of pain and depression
Friday, June 19, 2020 - 16:40
in Health & Medicine
Researchers have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system (CNS) and potentiating their natural painkilling and antidepressant properties.